YTHDF2 and central nervous system cancer: The expression of YTHDF2 in diffuse gliomas [88] promotes the deterioration of gliomas, and UBXN1, as a protein containing the UBX domain, inhibits the activation of NF-κβ by maintaining the expression of Iκβα.